Pharmaceutical Packaging

Gerresheimer AG reduced its 2026 revenue outlook to the lower half of the €2.3‑€2.4 billion range, citing project delays and operational challenges. Adjusted EBITDA margin guidance was cut to roughly

Gerresheimer AG cut its 2026 revenue outlook to the lower half of the €2.3‑€2.4 billion range. Adjusted EBITDA margin guidance was reduced to roughly 17‑18%, down from the prior 18‑19% range. Free cas